Evidence map›Paper›PMID 39227075›Full record

ArticleThe European respiratory journal2024

Worsening dyspnoea as a predictor of progression of pulmonary fibrosis.

Marlies S Wijsenbeek, Jeffrey J Swigris, Paolo Spagnolo, Martin Kolb, Michael Kreuter, Hilario Nunes, Wibke Stansen, Klaus B Rohr, Yoshikazu Inoue, INBUILD trial investigators

Abstract readLetter
In one paragraph

Article in The European respiratory journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Progressive pulmonary fibrosis: the importance of identification and intervention.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  4. A multidimensional index with SpORespiratory research & clinical practice · 2026
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marlies S WijsenbeekDepartment of Respiratory Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands m.wijsenbeek-lourens@erasmusmc.nl.
Jeffrey J SwigrisNational Jewish Health, Denver, CO, USA.
Paolo SpagnoloClinica di Malattie dell'Apparato Respiratorio, Dipartimento di Scienze Cardio-Toraco-Vascolari e Sanità Pubblica, Università degli Studi di Padova, Padova, Italy.
Martin KolbMcMaster University and St. Joseph's Healthcare, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0003-3837-1467
Michael KreuterMainz Center for Pulmonary Medicine, Department of Pneumology, ZfT, Mainz University Medical Center and Pulmonary, Critical Care and Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany.
Hilario NunesDepartment of Pulmonology, Hôpital Avicenne, APHP, Bobigny, France.
Wibke StansenBoehringer Ingelheim GmbH & Co. KG, Ingelheim am Rhein, Germany.
Klaus B RohrBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Yoshikazu InoueNational Hospital Organization Kinki-Chuo Chest Medical Center, Sakai City, Japan.ORCID https://orcid.org/0000-0003-3994-874X
INBUILD trial investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39227075
PMCPMC11525330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.